European Companies Search Engine
Convertible bonds Hrb5 Aug 2013 German Trade Register Announcements, Germany (31/07/2013)
Overview
Text
STADA Arzneimittel AG,
Bad Vilbel, Stadastraße 2 - 18, 61118 Bad Vilbel
. The Annual General Meeting of June 5, 2013 approved the amendment of Section 6 (Approved and Conditional Capital) as well a.s. amendments to Sections 15 (Supervisory Board Meetings),16 (Supervisory Board Resolutions), 21 (Participation) and 22 (Head of Management). The resolution of the Annual General Meeting of June 10, 2008 (Conditional Capital 2008/I) has been repealed. The share capital is conditionally increased by up to EUR 69,188,340, 00 by resolution of the Annual General Meeting on June 5, 2013 (Conditional Capital 2013/I). The conditional capital is used to grant shares to Inh. or creditors of warrants and/or convertible bonds, profit bonds and/or profit-sharing rights with option and/or conversion rights or obligations. The resolution of the Annual General Meeting of June 10, 2008 (Authorised Capital 2008/I) has been repealed. By resolution of the Annual General Meeting of June 5, 2013, the Management Board is authorized to increase the share capital by up to EUR 77,134,304 against cash and/or contributions in question once or several times by june 4, 2018 with the approval of the Supervisory Board, whereby the subscription rights of the shareholders can be excluded (Authorized Capital 2013/I). As not registered is announced
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: STADA Arzneimittel AG, Bad Vilbel, Germany.
The visualizations for "STADA Arzneimittel AG - Convertible bonds"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
